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EDITORIAL REVIEW
Role of reactive oxygen metabolites in experimental glomerular
disease
A large body of evidence accumulated over the last decade
indicates that partially reduced oxygen metabolites are impor-
tant mediators of ischemic, toxic and immune-mediated tissue
injury [1—101. In this review, I will define the term reactive
oxygen metabolites, briefly recount the sequence of events that
led to the consideration of these metabolites as important
mediators of tissue injury, and then present the available
evidence in support of the role of reactive oxygen metabolites in
glomerular disease. Oxygen normally accepts four electrons
and is converted directly to water. However, partial reduction
of oxygen can and does occur in biological systems, leading to
the generation of partially reduced and potentially toxic reac-
tive oxygen metabolites. Thus, when oxygen accepts one
electron, superoxide anion, a free radical, is generated.
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When oxygen accepts two electrons either directly or by the
dismutation of superoxide, hydrogen peroxide is formed. Fur-
ther reduction of oxygen leads to the generation of the highly
reactive hydroxyl radical. These oxygen metabolites including
the free radical species, superoxide and hydroxyl radical, and
other metabolites such as hydrogen peroxide and hypohalous
acids (derived from myeloperoxidase-hydrogen peroxide-halide
system), are often collectively referred to as reactive oxygen
metabolites.
The notion that reactive oxygen metabolites may be impor-
tant in inflammation was initiated by a publication in 1969, in
which McCord and Fridovich described an enzyme superoxide
dismutase [11], which scavenges superoxide anion. The chain
of events which led to the discovery of an enzyme with
superoxide dismutase activity has been eloquently recounted
by McCord and Fridovich [121. A few years earlier, Thomas
Schulte, Wolfgang Huber and co-workers, at a small pharma-
ceutical company called Diagnostic Data Inc., had isolated a
protein based on its anti-inflammatory properties. In 1971, it
was shown that superoxide dismutase isolated by McCord and
Fridovich and the anti-inflammatory protein isolated by Schulte
et al were one and the same. A rational hypothesis relating to
the anti-inflammatory activity and the superoxide dismutase
activity could not be formulated because very little was known
at that time concerning the biological sources and roles of
superoxide anion.
An important piece of information came in 1973 with the
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observation by Babior, Kipnes and Curnette [131 that phagocy-
tizing granulocytes generate superoxide anion, a free radical,
and that considerable amounts of these radicals are released
extracellularly. Babior's speculation that the radical is gener-
ated for bactericidal activity has now been well established and
indicates at least one functional role for reactive oxygen metab-
olites [1, 14, 15]. McCord reasoned that since phagocytizing
neutrophils, the effector cells of the acute inflammatory re-
sponse release large amounts of superoxide extracellularly and
that superoxide dismutase, an enzyme that scavenges superox-
ide possesses anti-inflammatory activity, superoxide anion and
other oxygen metabolites may be important chemical mediators
of the inflammatory process [16]. This hypothesis has received
considerable support from a large number of studies in which
the effect of reactive oxygen metabolites produced either by a
enzymatic generating system, such as xanthine-xanthine oxi-
dase or by activated leukocytes, has been examined in a variety
of biological systems as well as in vivo studies where scaven-
gers of reactive oxygen metabolites have been shown to be
protective.
Conceptually, evidence in support of the role of reactive
oxygen metabolites in glomerular disease will be presented as
follows: 1.) The potential sources of reactive oxygen metabo-
lites that could play a role in glomerular disease. 2.) Effects of
reactive oxygen metabolites on glomerular metabolism, their
role in glomerular basement membrane (GBM) degradation and
their effect on biological processes in other tissues relevant to
glomerular pathophysiology. 3.) Evidence from in vivo studies
for the role of reactive oxygen metabolites in glomerular injury.
Potential sources of reactive oxygen metabolites that could play
a role in glomerular diseases
Production of reactive oxygen metabolites by leukocytes
Several human and experimental glomerulonephritides are
characterized by the infiltration of glomeruli by neutrophils and!
or monocytes [17, 18]. The importance of leukocytes as medi-
ators of glomerular injury has been delineated in experiments in
which selective depletion of neutrophils [18] or monocytes [19]
led to amelioration of the glomerular injury. Although the
glomerular injury has been attributed to the release of enzymes
from leukocytes [20—22], studies from other tissues and recent
studies related to glomerular injury (vide infra) indicate that
neutrophil-derived reactive oxygen metabolites are also impor-
tant in tissue injury.
In response to plasma membrane perturbation by a variety of
soluble and particulate stimuli, neutrophils and monocytes!
macrophages not only release enzymes, but also exhibit a burst
of oxidative metabolism [23] (respiratory burst) with a marked
increase in oxygen uptake. It was originally thought that the
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increase in oxygen uptake was necessary to provide energy for
phagocytosis. However, when Sbarra and Karnovsky showed
in 1959 [24], that phagocytosis by neutrophils could occur
anaerobically, and subsequently others showed that several
soluble stimuli could also trigger the respiratory burst, it
became apparent that the increased oxygen uptake served
another purpose.
It is now known that most of the increased uptake of oxygen
is utilized by a plasma membrane-associated enzyme system to
catalyze one electron reduction of oxygen to superoxide anion.
The bulk of evidence seems to favor NAD(P)H as a physiolog-
ical electron donor.
202 + NAD(P)H > 202- + NAD(P) + H
The superoxide anion appears to be the most important source
for the production of hydrogen peroxide through the dismutase
reaction [25].
2 02- + 2 H > °2 + H202
Superoxide and hydrogen peroxide appear to be the primary
species generated; these may then play a role in the generation
of additional and more reactive oxidants including the hydroxyl
radical [2, 26, 27] and hypochlorous acid.
The direct interaction between superoxide and hydrogen
peroxide is rather slow, and it has been postulated that in
biological systems a trace metal such as iron participates in the
reaction commonly referred to as the metal-catalyzed Haber-
Weiss reaction. It has been suggested that superoxide can act as
a reductant for Fe3. The Fe2 then reduces the hydrogen
peroxide to hydroxyl radical by the Fenton reaction [2, 26, 271.
This reaction may be summarized as follows:
Fe3 + 02- > Fe + 02
Fe2 + H202 > Fe3 + OH + HO•
02- + H202 >02 + 0H + H0
This sequence of reactions has been alternatively termed su-
peroxide-driven Fenton's chemistry", acknowledging the role
of superoxide as a reductant and its intrinsic tendency for
dismutation to generate hydrogen peroxide. The precise source
of iron remains unknown [2]. It must be pointed out that while
several studies have clearly documented the generation of a
potent oxidizing species in the presence of a metal, the possi-
bility that the oxidant may not be hydroxyl radical has been
recently raised [281.
Additional reactive oxygen metabolites can be formed as a
result of the metabolism of hydrogen peroxide, by neutrophil
derived myeloperoxidase (MPO) to produce highly-reactive
toxic products including the hypochlorous acid. Myeloperox-
idase reacting with hydrogen peroxide forms an enzyme sub-
strate complex which has the capacity to oxidize various
halides producing highly reactive toxic products. Because of
the wide distribution of chloride ion in biologic systems, the
formation of hypochlorous acid (HOCI) is probably the most
significant product [1, 3, 4, 29].
MPO
11202 + Cl > HOCI + H20
Other hypohalous acids may also be generated, for example,
Weiss et al have recently reported the generation of hypobro-
mous acid by the eosinophils [30]. In addition, human neutro-
phils have been reported to generate long-lived (half-life ap-
proximately 18 hours) oxidants with characteristics similar to
N-chloramines [31].
Accompanying the oxidative burst (in response to either a
phagocytic or a soluble stimulus) leukocytes also emit light
(chemiluminescence). The light emission is due to the genera-
tion of electronically excited (in which electrons occupy orbit-
als of higher than ground state energy) states which upon
relaxation emit light. This was first demonstrated by Allen,
Stjernholm and Steel in 1972 [32] who postulated that singlet
oxygen was responsible for the light emission. Although the
mechanism of the generation of chemiluminescence by pha-
gocytes is complex, it appears to depend upon the production of
several species of oxygen including superoxide anion, hydrogen
peroxide, hydroxyl radical and perhaps singlet oxygen. Regard-
less of the mechanisms involved, the measurement of light
emission provides a sensitive index of the overall oxidative
metabolic potential of the phagocyte to stimulation [33—39] and
has been used as a sensitive measure of generation of reactive
oxygen metabolites by phagocytic cells.
As noted above, it is also clear that phagocytosis per se is not
essential to trigger the oxidative burst; perturbation of the
plasma membrane appears to be the critical event [4, 401. Of
particular interest is the demonstration that several immune
reactions (such as serum treated zymosan, a C3b receptor
stimulus [41]; heat aggregated IgG, Fc receptor stimulus [41];
immune complexes [42, 431 and complement components [41])
have all been shown to trigger the oxidative burst.
Production of reactive oxygen metabolites by glomerular cells
In proliferative glomerulonephritis, one potential source for
reactive oxygen metabolites could be the infiltrating neutrophils
and monocytes. But what about the non-proliferative glomeru-
lonephritis? Because of the presence of phagocyte-like cells in
the glomerulus (particularly mesangial cells) it was postulated
that glomerular cells, like other phagocytic cells, would also
generate reactive oxygen metabolites in response to a plasma
membrane pertubation [441. Thus, the ability of freshly isolated
rat glomeruli to generate reactive oxygen metabolites (as mea-
sured by luminol-amplified chemiluminescence) in response to a
plasma membrane perturbing agent, phorbol myristate acetate,
was examined. In response to phorbol myristate acetate (PMA),
rat glomeruli showed a marked chemiluminescence response
which reached a peak at about 20 minutes and declined gradu-
ally thereafter [441 (Fig. 1). Results with glomeruli isolated from
rats made leukopenic indicated that the response was not due to
contaminating" leukocytes (unpublished observations). Re-
sults with enzymic and chemical scavengers of oxygen metab-
olites indicated the involvement of superoxide anion, hydrogen
peroxide, and hydroxyl radicals in the phorbol-stimulated light
emission by glomeruli.
In a subsequent study the chemiluminescence response of
freshly isolated glomeruli to stimuli that may be biologically
relevant was examined [45]. Neutral proteases have been
shown to cause perturbation of plasma membrane and recent
studies indicate that plasma membrane-associated serine prote-
ases are essential for neutrophils [46], monocytes and alveolar
macrophages to generate superoxide in response to stimuli [46,
471. Basci and Shah reported that addition of chymotrypsin or
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Fig. 1. Time course of the chemiluminescence response by isolated rat
glomeruli. Chemiluminescence was measured with a liquid scintillation
system, operated in the out-of-coincidence summation mode. Incuba-
tion vials contained, in a total volume of 2 ml: luminol (final concen-
trations 3 x 10 M), Hanks' balanced salt solution, and glomeruli. At
time zero, either dimethylsulfoxide (open circles; resting values) or
phorbol myristate acetate in a final concentration of 10 sg/ml (closed
circles; stimulated values) was added, and cpm were obtained at time
intervals shown. Each point represents mean SEM of the number of
measurements indicated in parentheses.
trypsin results in a marked increase in the light emission from
the glomeruli [45]. Other serine proteases including thrombin,
an enzyme that is structurally similar to trypsin, or plasmin had
no significant effect on glomerular chemiluminescence. Neutral
proteases from infiltrating leukocytes and/or renal tissue have
been shown to be released in glomerular disease [481; these
results which show the generation of chemiluminescence in
response to neutral proteases suggest a potential mechanism for
the production of reactive oxygen metabolites in glomerular
diseases.
Several investigators have examined the ability of mesangial
cells to generate superoxide and hydrogen peroxide [49—54]. In
a study by Baud et al phagocytic activity was observed in about
50% of rat cultured mesangial cells incubated with opsonized
zymosan, and this was associated with a marked enhanced
generation of superoxide anion and hydrogen peroxide [49]. In
addition, incubation of mesangial cells with opsonized zymosan
resulted in the release of arachidonic acid and its transformation
into 11-, 12-, and l5-hydroxyeicosatetraenoic (HETE). Lipoxy-
genase inhibitors inhibited opsonized zymosan-stimulated hy-
drogen peroxide generation without affecting the phagocytosis.
Sedor, Carey and Emancipator have shown that in addition to
opsonized zymosan, both soluble and insoluble immune com-
plexes (bovine y globulin, anti-bovine y globulin) markedly
enhanced the generation of superoxide by cultured mesangial
cells [50]. Cultured mesangial cells from rats depleted of bone
marrow-derived phagocytes by irradiation produced amounts of
superoxide similar to cells from normal rats. Cytochalasin B did
not affect the generation of superoxide in response to immune
complexes [501, indicating that perturbation of the plasma
membrane rather than phagocytosis per se is the critical event
in triggering the generation of superoxide anion. Immune com-
plexes prepared from F(ab')2 fragments of antibody did not
stimulate superoxide release or bind to the mesangial cells.
These data suggest the presence of a receptor for the Fc region
of antibody on the mesangial cells which is required both for the
(6) binding and triggering the generation of superoxide.Membrane attack complexes in non-lethal concentrations
have been shown to stimulate the production of several poten-
tial inflammatory mediators, including prostaglandins and an
interleukin 1-like cytokine. Adler et a! have recently demon-
strated that glomerular mesangial cell membrane interaction
with membrane attack complexes stimulates the production of
both superoxide anion and hydrogen peroxide [51]. Mediators
of inflammation may also modulate the generation of reactive
oxygen metabolites by mesangial cells. Thus, platelet activating
factor has been shown to enhance the generation of superoxide
anion [52] and hydrogen peroxide [52], whereas the generation
of superoxide in response to opsonized zymosan was inhibited
by histamine [53]. Additional data suggested that histamine
inhibits the superoxide generation by stimulating cyclic AMP
accumulation, similar to an effect that has been reported in
other cellular systems. Interestingly, corticosteroids which are
widely used in the treatment of glomerulonephritis were re-
cently shown to inhibit phagocytosis-induced generation of
hydrogen peroxide by mesangial cells [54]. The results from
several investigators are presented in Table 1. These studies
clearly demonstrate the ability of glomerular mesangial cells to
generate reactive oxygen metabolites. In addition, studies from
other vascular beds [55] also suggest that glomerular endothelial
cells may be important sources of reactive oxygen metabolites.
Intracellular sources of reactive oxygen metabolites
Although most of the oxygen consumed by respiring cells is
utilized by cytochrome oxidase (which reduces oxygen directly
to water), at least some reduction of oxygen occurs via the
univalent path [5]. Precisely how much production of reactive
oxygen metabolites occurs in vivo is more difficult to determine
but is not insignificant, as evidenced by the ubiquity of the
intracellular defenses against reactive oxygen metabolites.
Thus superoxide is a minor but not a trivial product of biological
oxygen reduction [5]. Potential sources of oxidants include the
mitochondrial electron transport chain components, the endo-
plasmic reticulum and nuclear membrane electron transport
systems, the prostaglandin synthetase and lipoxygenase sys-
tems, soluble enzymes and proteins, endogenous autooxidiz-
able compounds, and xenobiotics and their metabolites [5, 6].
Enhanced intracellular generation of reactive oxygen metab-
olites has been suggested as being important in several disease
states, including Adriamycin cardiotoxicity [56] and most re-
cently reperfusion injury [7]. Recent studies suggest that these
observations from other tissues may be relevant to glomerular
pathophysiology. In addition to the well known cardiotoxicity,
a single intravenous injection of Adriamycin (an anthracycline
antibiotic used in cancer chemotherapy) causes nephrotic syn-
drome in rats [57, 58] with morphological and functional
changes similar to those seen in minimal change disease in
humans. Adriamycin undergoes a one-electron reduction to a
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Table 1. Generation of reactive oxygen me tabolites by glomerular cells
Chemiluminescence
Tissue Stimulus
Superoxide nmol Hydrogen peroxide nmol cpm x 1O/mg protein
Unstimulated Stimulated Unstimulated Stimulated Unstimulated Stimulated
Freshly isolated PMA 43 1675
glomeruli [44] 221
Freshly isolated Trypsin 16
glomeruli 145] Chymotrypsin 16 233
Mesangial cells [49] Serum treated 0 32 5 30
Mesangial cells [54]
zymosan
PMA
Serum treated
— 7a
— 64
zymosan
Calcium ionophore
A 23287
Platelet activating
factor
2
2
Mesangial cells [52] Platelet activating
factor
0 20b 2 4C
Mesangial cells [53] Serum treated 0 38C
Mesangial cells [50]
zymosan
Immune complexes 1 35"
Mesangial cells [51] Membrane attack
complexes
3 9 0 l2C
a nmol/l06 cells/30 mm
Ii
nmol/mg/5 mm
nmol/mg/30 mm
"nmol/mg/60 mm
nmolJlO6 cells/60 mm
Table 2. Evidence for the role of reactive oxygen metabolites (ROM) in biological processes relevant to glomerular pathophysiology
Biological process Tissue Source for ROM Comment
GBM degradation [811 Human GBM PMA-stimulated
human neutrophil
Hypochlorous acid generated by the stimulated
neutrophils activates a latent metalloenzyme which
then degrades the GBM.
GBM degradation [731 Rat GBM Pre-exposure of GBM to hydrogen peroxide increased its
susceptibility to subsequent proteolytic attack.
GBM degradation [74] Human GEM
Human GBM IgG-stimulated
human neutrophils
Pre-exposure of GBM to myleoperoxidase-hydrogen
peroxide increased its susceptibility to subsequent
proteolytic attack.
Scavengers of reactive oxygen metabolites did not affect
the GBM degradation.
Glomerular cyclic nucleotide Freshly isolated rat Xanthine-xanthine ROM increased cyclic AMP content in glomeruli,
content [89] glomeruli oxidase Hydrogen peroxide appears to be the responsible
oxygen metabolite for the observed effect.
Glomerular cyclic nucleotide Freshly isolated rat Opsonized zymosan- Hydrogen peroxide and hypochlorous acid generated by
content [90] glomeruli stimulated rat
neutrophils
the stimulated neutrophils increase cyclic AMP
content in glomeruli.
Prostaglandin and synthesis [98] Freshly isolated rat
glomeruli
Xanthine-xanthine
oxidase
The synthesis of PGE2, PGF2,, 6 keto PGF, TXB2 was
two fold higher in the presence of xanthine-xanthine
oxidase. Effect mediated by hydrogen peroxide via
activation of the glomerular phospholipase.
Prostaglandin synthesis [99] Rat mesangial cells Xanthine-xanthine
oxidase and
stimulated
neutrophils
Enhanced production of PGE2 in response to xanthine
oxidase or stimulated neutrophils.
Prostaglandin synthesis [100] Rat mesangial cells Xanthine-xanthine
oxidase
Exposure of mesangial cells of xanthine-xanthine oxidase
decreases the production of PGE2 and TXB2 after
stimulation by calcium ionophore or exogenous
arachidonic acid. This inhibitor effect is mediated by
hydrogen peroxide.
free radical, semiquinone species catalyzed by microsomes semiquinone radical is rapidly reoxidized in a process which
[59], sarcosomes [60], mitochondria [61], nuclei [62], and cyto- generates reactive oxygen metabolites. Thus, in vitro addition
plasm [63]. In the presence of molecular oxygen, Adriamycin of Adriamycin enhances superoxide and hydrogen peroxide and
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hydroxyl radical (or similar oxidant) generation in mitochondria
and microsomes [59—65]. Although definitive mechanisms of
Adriamycin's well-known cardiotoxicity have not been delin-
eated, the redox cycling of Adriamycin in biological systems
appears to be a critical event in its toxicity. Based on the
information related to cardiotoxicity, Adriamycin-induced ne-
phrotic syndrome appears to be a good model to demonstrate
the concept that reactive oxygen metabolites generated intra-
cellularly by glomerular cells can cause glomerular injury
resulting in proteinuria. In preliminary studies we have shown
that Adriamycin enhances the generation of superoxide and
hydrogen peroxide production by renal cortical microsomes
[66].
Xanthine oxidase was the first documented biological source
of superoxide, and in the presence of xanthine or hypoxanthine
generates superoxide, hydrogen peroxide, and a potent oxidiz-
ing species, presumably hydroxyl radical. In normal tissues, the
enzyme exists as a dehydrogenase utilizing NAD instead of
oxygen as the electron acceptor. The discovery that the enzyme
can be converted to its oxidase form following ischemia-
reoxygenation injury [67] has led to an explosive interest in the
role of this system and reactive oxygen metabolites in ischemic
injury in various organs [7, 8, 68], including the kidney [69]. In
addition, the xanthine oxidase generated reactive oxygen
metabolites may be important in glomerular injury. Recently
Diamond, Bonventre and Karnovsky [70] postulated that the
glomerular injury associated with puromycin aminonucleoside
(PAN) administration was mediated by oxygen free radical
generation since hypoxanthine, an intermediate metabolite of
PAN, can serve as a substrate for superoxide anion production
via the xanthine oxidase system (vidra infra). Indeed, in recent
preliminary communication it was shown that injection of PAN
(which results in marked proteinuria and glomerular morpho-
logical changes that are similar to minimal change disease in
humans) was associated with an increase in the xanthine
oxidase activity in glomeruli [71].
Thus, the potential sources for reactive oxygen metabolites
include infiltrating leukocytes and the generation of reactive
oxygen metabolites by glomerular cells, either by the perturba-
tion of plasma membrane or intracellularly.
Effects of reactive oxygen metabolites on glomerular
metabolism, their role in glomerular basement membrane
degradation and their effect on biological processes in other
tissues relevant to glomerular pathophysiology
Glomerular basement membrane degradation
Proteinuria is a hallmark of glomerular diseases. The critical
role played by the leukocytes in mediating glomerular injury has
been delineated by demonstrating that selective depletion of
neutrophils [72] ormonocytes [19] results in a marked reduction
in proteinuria. It is generally accepted that leukocytes cause
proteinuria by damaging the glomerular basement membrane
(GBM), which serves as the major ultrafiltration barrier to
restrict the entry of proteins into the urinary space. Indeed,
increased excretion of GBM fragments in the urine has been
observed in a variety of human and experimental glomerular
diseases [18, 20, 72].
The manner in which leukocytes cause damage to the GBM in
glomerulonephritis has been attributed to the release of lyso-
somal enzymes [18, 20, 72], in particular, the neutral protein-
ases. For example, elastase and cathepsin G obtained from
neutrophil homogenates were shown to degrade GBM [21].
Similarly intact neutrophils, when stimulated, degraded GBM
and this was inhibited by a serine proteinase inhibitor [22].
Several recent studies suggest that reactive oxygen metabo-
lites may influence the GBM degradation by proteolytic en-
zymes. Pre-treatment with hydrogen peroxide of partially-
purified rat GBM or basement membrane glycoprotein,
fibronectin, increased the susceptibility to subsequent proteo-
lysis [73]. In another study Vissers and Winterbourn [74]
reported that pre-exposure of GBM to neutrophil myeloperox-
idase, hydrogen peroxide, and chloride increased by two- to
threefold its susceptibility to proteolysis. These studies along
with studies of others [75, 76] which show that oxidant treat-
ment can render proteins more susceptible to proteolysis sug-
gest oxidants could contribute to GBM damage by increasing its
susceptibility to proteolytic damage (Table 2).
Recent studies have demonstrated that alpha-1-protease in-
hibitor (alpha-I -P1), the primary regulator of neutrophil elas-
tase, can be inactivated by a variety of oxidants, presumably
from the oxidation of the methionyl residues on the reactive site
[77—80]. It has been shown, for example, that reactive oxygen
metabolites generated by either the myeloperoxidase-hydrogen
peroxide-halide system [79] or by human neutrophils in re-
sponse to immune complexes [77] inactivated alpha-1-PI. In a
more recent study, the ability of triggered neutrophils to de-
grade endothelial cell matrix in presence of alpha-l-PI was
unaffected by superoxide dismutase or hydroxyl radical scav-
engers but was markedly decreased by catalase, azide (myelo-
peroxidase inhibitor), or hypochlorous acid scavengers [80].
Taken together, these findings suggest that the oxidants gener-
ated by the stimulated neutrophils can inactivate the alpha-l-PI,
thus allowing the released elastase to more readily inflict
damage to the extracellular matrix.
In contrast to these effects of the oxidants which would
enhance the damage to extracellular matrix, Vissers and Win-
terbourn [74] reported that the activity of elastase was 1.5 to 2
times higher from neutrophils that were stimulated with im-
mune complexes in presence of catalase, but were unaffected
by superoxide dismutase or hydroxyl radical scavengers. This
would suggest that the oxidants by inactivating proteinases
responsible for GBM damage may reduce the damage to the
GBM. In this study the authors concluded that the myleoper-
oxidase-derived oxidants produced by neutrophils have two
opposing effects on degradation of extracellular matrix compo-
nents by these cells. Although they can render the proteins
more susceptible to proteinases released from cells, this is a
small effect and largely offset by oxidative inactivation of
enzymes themselves.
Shah, Baricos and Basci have examined the role of reactive
oxygen metabolites in the degradation of human GBM by
stimulated human neutrophils [81]. Neutrophils stimulated with
PMA caused a significant degradation of GBM compared to the
release by unstimulated neutrophils. They demonstrated that
the degradation of the GBM by PMA-stimulated neutrophils is
due to the activation of a latent metalloenzyme by hypochlo-
rous acid or a similar oxidant generated by the myleoperoxi-
dase-hydrogen peroxide-halide system. The activation of colla-
genase [82] and gelatinase [83] by reactive oxygen metabolites
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has been similarly described in recent studies. Recent studies
suggest that the metalloenzyme responsible for the degradation
of the GBM is most likely gelatinase [84, 85]. It must be
emphasized that the oxidative mechanism is not the only
mechanism for activation of the metalloenzymes. For example,
recently Vissers and Winterbourn reported a marked activation
of neutrophil gelatinase by serine proteinases, particularly
elastase [841. Thus the neutrophul can potentially activate its
metallozenzymes by a proteolytic or an oxidative mechanism.
Nonetheless, prevention of proteinuria by catalase in neutro-
phil-dependent glomerulonephritides suggests that the oxida-
tive mechanism for GBM degradation described may be quite
relevant to leukocyte-dependent glomerutar injury (vide infra).
Effect of reactive oxygen metabolites on the cyclic nucleotide
content in isolated rat glorneruli
There is increasing evidence for the importance of cyclic
nucleotides in glomerular pathophysiology. For example, infu-
sion of dibutyl cyclic AMP and several hormones which in-
crease cyclic AMP content in glomeruli caused a fall in the
glomerular ultrafiltration coefficient [86]. In addition, the cyclic
nucleotide content in glomeruli is altered most strikingly by
several local mediators of inflammation (serotonin, histamine,
prostaglandins), suggesting that as in other systems, cyclic
nucleotides may. modulate the inflammatory and/or immune
response in glomerular disease [87, 88].
Because other mediators of inflammation markedly alter the
cyclic nucleotide content in glomeruli, Shah examined the effect
of reactive oxygen metabolites (generated by the xanthine-
xanthine oxidase system) on cyclic AMP and cyclic GMP
content in glomeruli and tubules isolated from rat renal cortex
[89]. Xanthine by itself or xanthine oxidase by itself had no
effect whereas the cyclic AMP content in glomeruli was in-
creased two- to threefold in the presence of xanthine-xanthine
oxidase. Allopurinol, a specific inhibitor of xanthine oxidase,
markedly impaired the cyclic AMP response to xanthine-xan-
thine oxidase, indicating that the observed effect was due to
xanthine oxidase acting on its substrate, xanthine, rather than
due to contaminating proteases. Cyclic AMP content in the
tubules, and the cyclic GMP content in the glomeruli and
tubules was not affected by the xanthine-xanthine oxidase
system. The marked inhibition by catalase, the lack of effect of
superoxide dismutase along with an increase in the cyclic AMP
content in glomeruli with glucose-glucose oxidase (a system
that directly generates hydrogen peroxide), suggested hydrogen
peroxide as the responsible oxygen metabolite for the observed
effect. These results show that reactive oxygen metabolites
increase cyclic AMP content in glomeruli and that hydrogen
peroxide appears to be the responsible oxygen metabolite for
the observed effect.
While the critical role played by leukocytes in proteinuria is
generally accepted, the notion that infiltrating leukocytes in
proliferative glomerulonephritides may modulate the inflamma-
tory response and glomerular function by altering glomerular
metabolism had not been previously considered. Based on the
effect of xanthine-xanthine oxidase on the cyclic AMP content,
Basci, Wallin and Shah postulated that reactive oxygen metab-
olites produced by infiltrating leukocytes may modulate the
inflammatory response in glomerular diseases by altering levels
of cyclic nucleotides [90]. Cell-free supernatants from stimu-
lated rat neutrophils caused a threefold increase in the cyclic
AMP content in the glomeruli. Results with scavengers of
reactive oxygen metabolites indicated an important role for
hydrogen peroxide and hypochlorous acid in increasing the
cyclic AMP content of the glomeruli by stimulated neutrophils.
Additional experiments that used prostaglandin synthesis inhib-
itors (meclofenamate and ibuprofen) suggested that the reactive
oxygen metabolites increase the cyclic AMP content by en-
hancing the glomerular prostaglandin synthesis. These data
show that reactive oxygen metabolites generated by stimulated
neutrophils increase cyclic AMP content in glomeruli, and
suggest that neutrophils may modulate the glomerular function
and the inflammatory response in glomerular disease by altering
the cyclic AMP content.
Effect of reactive oxygen metabolites on eicosanoid synthesis
by glomeruli
Production of prostaglandins and thromboxanes by isolated
glomeruli and cultured glomerular cells has been well demon-
strated [91—93]. Because these autocoids exert important effects
on glomerular hemodynamics, it has been postulated that the
release of these locally active hormones may play an important
role in glomerular pathophysiology [91]. Increased production
has been demonstrated in various human and experimental
glomerulopathies [94, 95]. In addition, thromboxanes have been
implicated as important mediators causing proteinuria and/or a
fall in the GFR in anti-GBM antibody disease [96], and
Adriamycin-induced nephrotic syndrome in rats [58] and com-
plement-mediated glomerular injury [97].
Studies from other organs and cultured cells have shown
reactive oxygen metabolites to both stimulate and inhibit the
cyclooxygenase pathway. Baud et al have examined the effect
of enzymatically-generated (xanthine-xanthine oxidase) reac-
tive oxygen metabolites on prostaglandin production by freshly
isolated glomeruli [98]. The synthesis of PGE2, PGF2a, 6
ketoPGF1, (the stable metabolite of prostacyclin) and TXB2
(the stable metabolite of thromboxane), was twofold higher in
the presence of xanthine-xanthine oxidase. Inhibition by cata-
lase and direct stimulatory effect of hydrogen peroxide sug-
gested hydrogen peroxide as the metabolite responsible for the
observed effect. Additional experiments suggested the effect of
hydrogen peroxide was due to activation of the glomerular
phospholipase. Similarly, the enhanced production of POE2 by
mesangial cells in response to hydrogen peroxide generated
either by xanthine-xanthine oxidase or stimulated neutrophils
has been reported [99].
These studies indicate that the basal levels of prostaglandin
production by glomerular cells is increased by hydrogen perox-
ide. In contrast to these effects on the basal level of prostaglan-
din production, Adler et at have reported that exposure of
mesangial cells to the reactive oxygen generating system de-
creases the production of PGE2 and TXB2 after stimulation by
calcium ionophore or exogenous arachidonic acid [100]. This
inhibitory effect is mediated by hydrogen peroxide as demon-
strated by the use of scavengers and by the direct effect of
hydrogen peroxide.
Thus, reactive oxygen metabolites affect several biological
processes in glomeruli including affecting cyclic AMP levels,
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enhancing PG synthesis and participating in the degradation of
GBM.
Effect of reactive oxygen metabolites on biological processes
in other tissues relevant to glomerular pathophysiology
Reactive oxygen metabolites may play a role in chemotaxis,
since plasma exposed to superoxide in vitro is chemotactic and
intradermal injection of superoxide treated plasma or a super-
oxide generating system causes heavy infiltration of neutrophils
to the injection site [101]. This chemotactic agent has been
tentatively identified as a heat labile lipid that is bound to
albumin. The ability of a reactive oxygen generating system to
generate a chemotactic lipid from arachidonic acid has also
been demonstrated [102]. These observations suggest the pos-
sibility that reactive oxygen metabolites may play a role in
chemotaxis in those glomerular diseases in which the mecha-
nism for leukocyte infiltration is not known. Indeed, in several
models of inflammation including a model of glomerulonephritis
in the mouse, superoxide dismutase has been shown to mark-
edly reduce neutrophil infiltration [16].
There is increasing evidence that platelets participate in the
development of local glomerular injury, especially in immune
complex glomerulonephritis [103]. A superoxide generating
system [104] and the myeloperoxidase-hydrogen peroxide-ha-
lide system [105, 106] have been shown to cause a release of
platelet constituents in non-lytic concentrations. In turn, plate-
lets have been shown to enhance the generation of reactive
oxygen metabolites by stimulated neutrophils [107], suggesting
one mechanism by which platelets may enhance the tissue
damage. Evidence in support of this concept has been recently
provided by demonstrating platelet depletion provided signifi-
cant protection [1081 in two models of lung injury which are
known to be mediated by neutrophil-derived oxygen metabo-
lites and in a model of neutrophil-dependent glomerulonephritis
[109]. These interactions between reactive oxygen metabolites
and platelets may be quite relevant to glomerular disease, as
evidenced by a recent report in which infusion of myeloperox-
idase-hydrogen peroxide in the renal artery caused glomerular
injury that was associated with marked influx of platelets in the
glomerular capillaries [110].
Evidence from in vivo studies for the role of reactive oxygen
metabolites in glomerular injury
Proteinuria is a major manifestation of glomerular disease,
reflecting increased vascular permeability (due to loss of either
size and/or charge selective barrier) to macromolecules includ-
ing albumin. Several investigators have clearly demonstrated
that scavengers of reactive oxygen metabolites have been
protective in several models of tissue injury characterized by
increased vascular permeability. The models examined include
the lung injury induced by hyperoxia [Ill], by cobra venom
factor [112, 113], by IgA immune complexes [114], by thermal
trauma to skin [1151, and in isolated perfused rat lung prepara-
tion exposed to enzymatically-generated reactive oxygen
metabolites [1161. These studies from other tissues thus suggest
that reactive oxygen metabolites, by altering glomerular vascu-
lar permeability, may play a role in proteinuria, a major
manifestation of glomerular disease (Table 3).
Neutrophil-dependent glomerular injuly
The role of reactive oxygen metabolites generated by neutro-
phils in glomerular injury has been recently demonstrated in
several studies. PMA is a well known potent activator of
leukocytes resulting in the generation of reactive oxygen metab-
olites, and previous studies have shown that instillation of PMA
in lungs results in lung injury that is dependent on the genera-
tion of reactive oxygen metabolites. Based on these observa-
tions, Rehan et a! examined the ability of PMA to induce
glomerular injury [117]. When selectively infused in the renal
artery, PMA caused significant proteinuria which was accom-
panied by neutrophil infiltration and morphological evidence Of
glomerular damage. Neutrophil depletion as well as co-instal-
lation of catalase (but not superoxide dismutase) prevented the
proteinuria, suggesting that hydrogen peroxide and/or its
metabolites derived from neutrophils were important in the
PMA-induced proteinuria. Further evidence that reactive oxy-
gen metabolites generated by neutrophils can cause proteinuria
is derived from studies where activation of the complement
system in the kidney by selective infusion of cobra venom
factor in the renal artery caused proteinuria, which was pre-
vented by catalase and neutrophil depletion [118]. Taken to-
gether, these studies with PMA and cobra venom factor indi-
cate that hydrogen peroxide and/or its metabolites generated by
the neutrophils can cause proteinuria.
Johnson et a! reasoned that hydrogen peroxide mediated
injury may involve the myeloperoxidase-hydrogen peroxide-
halide system [119]. This postulate is particularly attractive in
view of the highly cationic nature of myeloperoxidase (isoelec-
ti-ic point> 10) and recent studies that demonstrate glomerular
localization of neutrophil and platelet-derived cationic proteins
in glomerulonephritis. They demonstrated that infusion of my-
eloperoxidase followed by hydrogen peroxide in a chloride
containing solution into the renal artery in rats results in
significant proteinuria, endothelial cell swelling, and epithelial
cell foot process effacement, accompanied by halogenation of
the GBM [119]. Recently, Johnson et al have reported that four
to ten days after infusion of hydrogen peroxide and myleoper-
oxidase, a marked proliferative glomerular lesion develops with
about a 30 to 59% increase in the resident glomerular cells [110].
In addition, recently they have also presented evidence for the
participation of the myeloperoxidase-hydrogen peroxide-halide
in a model of neutrophil-mediated immune complex glomerulo-
nephritis [120]. Halogenation (as measured by the incorporation
of 1251) of glomeruli and GBM was demonstrated in an in situ
model of immune complex glomerulonephritis (concanavalin
A-anti-concanavalin model). Glomerular iodination could not
be demonstrated in neutrophil-independent model of nephro-
toxic nephritis induced by noncomplement fixing anti-GBM
antibody. These studies indicate the activation of the myeloper-
oxidase-hydrogen peroxide-halide system in a model of neutro-
phil-mediated immune complex glomerulonephritis and that the
system is capable of inducing glomerular injury that results in
proteinuria.
In addition to increased glomerular permeability, the other
common manifestation of glomerular disease is a fall in glomer-
ular filtration rate (GFR). The role of reactive oxygen metabo-
lites generated by neutrophils on glomerular function has been
recently examined in several studies with conflicting results.
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Cationized gamma globulin-induced immune complex No
GN [137]
Yes Proteinuria prevented by catalase but not SOD.
The fall in whole kidney GFR not prevented
by catalase.
Yes A fall in the single nephron GFR and an
elevation of PGC in association with a
decrease in ultrafiltration coefficient (K1) and
an increase in efferent arteriolar resistance.
These changes in glomerular function
prevented by catalase.
Yes Proteinuria prevented by catalase but not SOD.
The fall in whole kidney GFR not prevented
by catalase.
ND Significant proteinuria, endothelial cell swelling,
epithelial cell foot process effacement,
accompanied by halogenation of the GBM at
24 hours. Four to ten days later a marked
proliferative glomerular lesion develops.
Yes Halogenation (as measured by the incorporation
of 1251) of glomeruli and GBM was
demonstrated in an in situ model of immune
complex glomerulonephritis.
Yes Catalase markedly reduced the proteinuria,
whereas SOD had no protective effect in the
heterologous phase.
Yes A hydroxyl radical scavenger and an iron
chelator significantly attenuated the anti-GEM
antibody-induced proteinuria in the
heterologous phase.
ND SOD and PEG catalase significantly reduced
proteinuria in the accelerated autologous
phase.
ND SOD had no effect on proteinuria in the
accelerated autologous phase.
No Allopurinol (an inhibitor of xanthine oxidase)
and SOD were protective, suggesting a role
for xanthine oxidase generated superoxide
anion in this model of minimal change.
No SOD and PEG-catalase significantly reduced
proteinuria.
No Hydroxyl radical scavengers and iron chelator,
deferoxamine, significantly reduced
proteinuria.
No SOD and catalase had no effect whereas
hydroxyl radical scavengers and iron chelator,
deferoxamine, significantly reduced
proteinuria in this model of membranous
nephropathy.
No SOD and catalase had no effect whereas two
hydroxyl radicals significantly reduced the
proteinuria.
Rehan et al observed that PMA infusion or infusion of cobra
venom factor reduced the whole kidney GFR by about 50 to
90% but catalase (in doses that reduced the proteinuria) did not
prevent the fall [117, 118]. They concluded that while the
reactive oxygen metabolites are important in the increase in
glomerular permeability following infusion of PMA or cobra
venom factor, different mechanisms mediate the decrease in
GFR. In a preliminary communication, Yoshioka, Badr and
Ichikawa [121] have reported that unilateral infusion of PMA
led to a fall in the single nephron GFR and an elevation of PGC
in association with a decrease in ultrafiltration coefficient (K1)
and an increase in efferent arteriolar resistance. Neutrophil
depletion or pre-treatment with catalase prevented these
changes. These results indicate that reactive oxygen metabo-
lites generated by neutrophils evoke a profound constrictive
response in the glomerular microcirculation and that the effects
of reactive oxygen metabolites are localized primarily on the
efferent arteriole and the glomerular capillary.
Anti-GBM antibody disease
The role of reactive oxygen metabolites has been examined in
nephrotoxic serum nephritis, the classic experimental model for
the study of glomerular injury induced by anti-OBM antibodies.
Although less than 5% of glomerulonephritis in man is mediated
by anti-GBM antibody, many of the current concepts of immu-
nologic mediation of glomerular injury have been derived from
Table 3. In vivo evidence for the role of reactive oxygen metabolites in glomerular injury
Complement Neutrophil
Model dependent dependent Comments
Infusion of PMA [117] No
Infusion of PMA [121] ND
Infusion of cobra venom factor [118] Yes
Infusion of myleo-peroxidase-hydrogen peroxide ND
[110, 119]
Concanavalin A-anti-concanavalin A antibody [120] ND
Anti-GBM antibody [123] Yes
Anti-GEM antibody [125] Yes
Anti-GBM antibody [129] ND
Anti-GBM antibody [130] ND
Injection of puromycin aminonucleoside [70] No
Injection of puromycin aminonucleoside [1391 No
Injection of puromycin aminonucleoside [142] No
Injection of anti-FxIA antibody [136] Yes
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experimental studies of anti-GBM models. After a single intra-
venous injection of anti-GBM antibody the proteinuria occurs
in two phases: the heterologous phase (usually defined as
proteinuria in the first 24 hours) is the result of the binding of the
administered antibody to the GBM, and the second autologous
phase occurs several days later when the bound antibody elicits
an antibody response from the host [1221.
Rehan et al examined the role of reactive oxygen metabolites
in the complement and neutrophil-dependent proteinuria in the
heterologous phase of anti-GBM antibody induced glomerular
injury in rats [123]. Treatment of animals with catalase mark-
edly reduced the proteinuria, whereas superoxide dismutase
had no protective effect. These data suggested that acute
glomerular injury produced by anti-GBM antibody is related to
hydrogen peroxide production by the activated rieutrophils.
Rehan et al also reported that dimethyl sulfoxide, a hydroxyl
radical scavenger, had no protective effect in the anti-GBM
antibody disease. However, a lack of protective effect of a
particular oxygen radical scavenger does not exclude the role of
that radical in tissue injury. In particular with dimethyl sulf-
oxide this lack of protection may be related to the generation of
toxic methyl radicals or methylperoxy radicals by the interac-
tion between dimethyl sulfoxide and hydroxyl radical [1241.
Boyce and Hold sworth examined the role of hydroxyl radical
in the complement and neutrophil dependent heterologous
phase of anti-GBM antibody disease in rabbits [125]. In a
finding similar to that reported by Rehan et a! they found no
protective effect of dimethyl sulfoxide. However dimethyl-
thiourea (DMTU), a potent hydroxyl radical scavenger, signif-
icantly attenuated the anti-GBM antibody-induced proteinuria.
However, it should be noted that a recent study by Wasil et al
[126] indicates that DMTU is also able to scavenge hypochlo-
rous acid—the product generated by the neutrophil myeloper-
oxidase—hydrogen peroxide and halide system. Thus in neu-
trophil-dependent injuries the protective effects of DMTU may
be either due to the scavenging of hydroxyl radical or by
scavenging hypochiorous acid.
Although the role of iron is not completely understood, the
protective effect of iron chelators has been generally taken as
evidence for the participation of hydroxyl radical in tissue
injury because iron is critical in the generation of hydroxyl
radical (via the Haber-Weiss reaction). Indeed, in in vitro
studies, the ability of deferoxamine to block the generation of
hydroxyl radical has been well demonstrated [127]. Thus the
role of hydroxyl radicals in tissue injury has been delineated not
only by demonstrating the protective effect of hydroxyl radical
scavengers but also by demonstrating the protective effect of
iron chelators. Iron chelators, including deferoxamine and 2,3,
dihydroxybenzoic acid, have been shown to be protective in
several in vivo models of tissue injury [112—115, 128]. Boyce
and l{oldsworth have demonstrated that the administration of
deferbxamine prevented the development of proteinuria in the
complement and neutrophil-dependent heterologous phase of
anti-iBM antibody disease in rabbits [125]. Although the
requirement for iron could also be explained by a reaction
involeing the formation of the perferryl ion [15], a protective
effect of both the hydroxyl radical scavengers and the iron
chelators imply a role for hydroxyl radical.
Thse studies indicate that reactive oxygen metabolites may
play an important role in the increased glomerular permeability
in the neutrophil and complement dependent heterologous
phase of anti-GBM antibody disease. The complement system
does not appear to play an important role in the autologous
phase which occurs when the bound antibody elicits an anti-
body response from the host. However, recent studies indicate
antimacrophage antiserum markedly reduces the proteinuria,
suggesting an important role of monocytes in the autologous
phase of anti-GBM antibody disease. As discussed earlier,
activated monocytes also generate reactive oxygen metabolites,
suggesting the possibility that reactive oxygen metabolites may
be important in the autologous phase of anti-GBM antibody
disease. In a preliminary report, Birtwistle et a! [129] have
shown that both superoxide dismutase and PEG-catalase re-
duced the proteinuria in the accelerated autologous model of
anti-GBM antibody. In contrast, Webb et al [130] reported no
protective effect of superoxide dismutase in the accelerated
autologous model of anti-GBM antibody. Since anti-GBM an-
tibody can cause proteinuria in isolated perfused kidney (thus
independent of neutrophils or monocytes) [131] it is conceivable
that the lack of effect reported by Webb et a! [130] may be due
to using an anti-GBM antibody that can cause proteinuria
independent of monocytes.
Taken together the studies with PMA, cobra venom factor
and studies in the heterologous phase of anti-GBM antibody
disease demonstrate that reactive oxygen metabolites generated
by activated neutrophils play an important role in altering
glomerular permeability. The information regarding their role in
altering glomerular function is not as extensive and is con-
flicting.
Neutrophil-independent glomerular injury
The ability of freshly isolated glomeruli [44, 45] or cultured
mesangial cells to generate reactive oxygen metabolites in
response to several stimuli [49—54] suggests that reactive oxy-
gen metabolites may also play a role in glomerular diseases that
lack infiltrating leukocytes.
Passive Heymann nephritis
In rats, passive Heymann nephritis is a model in which there
is in situ binding of the anti-Fx1A antibody with a fixed
glomerular antigen resulting in a model that resembles membra-
nous nephropathy in humans [132, 133]. Passive Heymann
nephritis, induced by a single intravenous injection of anti-
Fx1A, is a complement-dependent [133—135] and neutrophil-
independent model of glomerular disease. Shah reported that
superoxide dismutase or catalase (native or polyethylene gly-
col-coupled [PEG]) did not affect the anti-Fx!A-induced pro-
teinuria [136]. In contrast, dimethylthiourea, and sodium ben-
zoate, both scavengers of hydroxyl radical, markedly reduced
the proteinuria. Experiments with '251-labelled anti-Fx1A anti-
body demonstrated that DMTU did not affect the amount of
antibody deposited in the kidney. Semi-quantitative estimation
of IgG and complement deposition in the kidney showed no
differences between the DMTU-treated and control rats. There
was a significant reduction in proteinuria in rats treated concur-
rently with deferoxamine. The protective effects of both the
hydroxyl radical scavengers and an iron chelator suggest a
potential role of the hydroxyl radical in passive Heymann
nephritis.
Rahman, Emancipator and Sedor have [137] examined the
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role of reactive oxygen metabolites in the cationized gamma
globulin-induced immune complex glomerulonephritis. a com-
plement and neutrophil-independent model of membranous
nephropathy. Neither superoxide dismutase nor catalase had
any effect on proteinuria. In contrast, two hydroxyl radical
scavengers, dimethyl sulfoxide and dimethylthiourea, signifi-
cantly reduced the proteinuria, suggesting a role of hydroxyl
radical in this immune complex glomerulonephritis. Taken
together these studies suggest an important role of hydroxyl
radical in animal models of membranous nephropathy.
Puromycin aminonucleoside-induced proteinuria in rats
A single intravenous injection of PAN results in marked
proteinuria and glomerular morphological changes that are
similar to minimal change disease in humans [138]. Recently
Diamond, Bonventre and Karnovsky postulated that the gb-
merular injury associated with PAN was mediated by oxygen
free radical generation since hypoxanthine, an intermediate
metabolite of PAN, can serve as a substrate for superoxide
anion production via the xanthine oxidase system [701. They
reported that allopurinol (an inhibitor of xanthine oxidase) and
superoxide dismutase were protective in PAN-induced ne-
phrotic syndrome, suggesting a role for xanthine oxidase-
generated superoxide anion in this model of minimal change
disease [70]. In biological systems, enhanced generation of
superoxide is accompanied by enhanced generation of hydro-
gen peroxide. Beaman et al [139] confirmed the protective effect
of superoxide dismutase and in addition reported that protein-
uria was significantly reduced in rats receiving PEG-catalase,
suggesting a role of both hydrogen peroxide and superoxide
anion in this model of glomerular disease.
Superoxide anion and hydrogen peroxide may interact (with
iron as catalyst) to generate the hydroxyl radical. Several
studies have, in fact, shown that enhanced generation of
hydrogen peroxide and superoxide anion is accompanied by
enhanced generation of hydroxyl radical (or a similar highly
oxidizing species) [140, 1411. Thakur et al postulated that
enhanced generation of superoxide anion and hydrogen perox-
ide would lead to enhanced generation of hydroxyl radical
which would play a role in the proteinuria in this model. They
reported protective effects of two hydroxyl radical scavengers
and an iron chelator [142], implicating an important role for
hydroxyl radical in PAN-induced nephrotic syndrome.
Conclusions and perspective
Reactive oxygen metabolites have been implicated in the
development of tissue injury in an increasing number of dis-
eases [9]. While it is currently popular to incriminate oxygen
metabolites as ultimate injurious agents, given the complexity
and multifaceted nature of inflammation, the cooperative and
sometimes complex interaction between different injurious
mechanisms appears much more likely [143]. The interaction
between proteases and oxidants in the degradation of GBM is
just one example of this.
In in vivo studies most investigators have relied on scaven-
gers of reactive oxygen metabolites to implicate these in the
tissue injury. The demonstration that the in vivo generation of
reactive oxygen metabolites is enhanced (coupled with the
protective effect of scavengers) would greatly strengthen the
argument for the role of reactive oxygen metabolites in a
particular model of tissue injury. Some progress is being made
in other tissues [144], but there is virtually no information about
in vivo generation of reactive oxygen metabolites by kidneys in
general and by glomeruli in particular. In addition, recently,
important attempts have been pursued by a number of investi-
gators to demonstrate that oxygen products are generated in
tissues by detecting the products of their action, such as lipid
peroxidation [112, 143, 145, 146]. That they have affected
specific targets may also be determined by measuring glutathi-
one (GSH), glutathione disulfide ("oxidized" glutathione,
GSSG), and GSH/GSSG ratio in such cells [147, 148].
The glomerular injury by reactive oxygen metabolites is
determined not only by enhanced generation, but also by the
enzymatic and non-enzymatic defenses of reactive oxygen
metabolites [149—156]. There is virtually no information on the
levels of superoxide dismutase, catalase and glutathione perox-
idase and glutathione in the glomeruli, whether they are altered
in models of glomerular diseases, and their importance as
evaluated by examining the effect of reducing the levels of the
scavengers in various models.
In most of the models of glomerular disease studied, the
scavengers of reactive oxygen metabolites have been adminis-
tered at the time of injury. While these studies enhance our
understanding of the initial mechanism of glomerular injury,
there is no assurance that administration of these scavengers
after the injury has been initiated will have beneficial results. In
contrast, a sufficient body of information exists with ischemic-
reperfusion injury to the heart and to the kidney (post-renal
transplant acute renal failure) to warrant clinical trials, some of
which have already begun [157]. Similar therapeutic benefit of
scavengers or iron chelators may also be possible in aminogly-
coside-induced acute renal failure [128]. We may be beginning
to see the exciting basic science research being translated into
therapeutic strategies for patients.
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